|
||||
|
Product trade name: Tritace Titration Pack
Pharmaceutical active ingredients containing related brand and generic drugs, medications or other health care products: Tritace Titration Pack available forms, composition, doses: Tritace Titration Pack destination | category: Indications and usages, anatomical therapeutic chemical and diseases classification codes: Pharmaceutical companies, researchers, developers, manufacturers, distributors and suppliers: Online pharmacy, drugstores, pharma, health and beauty shops selling this or related pharmaceutical products: There is an additional general information about this medication active ingredient ramipril: Tritace Titration Pack information Tritace Titration Pack belongs to the class of drugs classified as ACE inhibitors or Angiotensin-Converting-Enzyme inhibitor. Tritace Titration Pack indications This product is a drug prescribed for the treatment of hypertension or high blood pressure, and for the prevention of heart failures succeeding heart attacks. Tritace Titration Pack is also used for the prevention of heart attacks, stroke and other heart related problems. Tritace Titration Pack warnings The medication is major allergen especially to patients who have had histories of allergies. Ask for a skin test from your doctor if you are a person prone to allergies and more importantly if you are allergic to the components of Tritace Titration Pack. Before taking the medicine, inform your doctor if you have: liver disease kidney disease And if you are on a salt restricted diet or taking salt substitutes, your doctor may lower you Tritace Titration Pack dosage or even forbid you to take the drug. Tritace Titration Pack is also a grudge belonging to the pregnancy category D, which means that this medicine is a sure cause of birth defects in babies and may even cause death in the 2nd and third trimester of pregnancy. The components of Tritace Titration Pack are also passed through breast milk and the degree of harmful effects on the nursing infant is not known. Talk to your doctor first before deciding to take Tritace Titration Pack if you are breast feeding. Never take Tritace Titration Pack when performing tasks that require mental and physical alertness such as driving or operating any kind of machinery. This medication is a powerful cause of drowsiness and dizziness. Always maintain proper hydration when taking this medicine. Lack of fluids may cause low blood pressure and may enhance dizziness and fainting. Tritace Titration Pack intake guidelines This medicine should be taken exactly as it is prescribed by your doctor. Each dose must be taken with a full glass of water of about 6-8 ounces. The intake of Tritace Titration Pack can be with or without food. Never stop medication without first consulting your doctor even if you begin to feel better, it still important that your termination of use of this medicine must be properly supervised by your doctor. Tritace Titration Pack dosage The dosage of Tritace Titration Pack can only be effectively determined by your doctor. Tritace Titration Pack overdose If symptoms of overdose such as extreme drowsy and dizzy feeling, weakening, fainting and fatigue settles in, immediately seek medical help. Tritace Titration Pack missed dose Do not take double doses of Tritace Titration Pack; instead, skip the dose you missed especially if it near the time for the next dose. Tritace Titration Pack side effects Possible side effects of Tritace Titration Pack may include: allergic reactions difficulty in urinating arrhythmia changes in heartbeat chest pains severe drowsiness sore throat fever headache fatigue dry tickling cough nausea vomiting diarrhea anxiety and depression If you experience any of these side effects and if they become bothersome and intolerable, consult your doctor. Tritace Titration Pack drug reactions This drug may react with drugs that contain potassium and potassium supplements such as K-Dur and Klor-Con. Diuretics may also not work well with Tritace Titration Pack as well as water pills such as Lasix, Bumex and Lozol.
Comments
|
|
|||
|
||||